Paroxetine: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Paroxetine. Educational only — not medical advice.

Reported adverse reactions

ReactionHighest frequency reported*
Ejaculatory disturbance27%
Abnormal ejaculation26%
Dry mouth15%
Dyspepsia13%
Decreased libido13%
Constipation10%
Female genital disorder10%
Orgasmic disturbance10%
Infection8%
Nervousness8%
Sinusitis8%
Abdominal pain7%
Libido decreased7%
Tremor7%
Female genital disorders7%
Nausea*6%
Flatulence6%
Sweating6%
Back pain5%
Trauma5%

*Highest percentage across placebo-controlled trial tables summarized in current labeling.

Labeled uses

INDICATIONS AND USAGE Major Depressive DisorderPAXIL CR is indicated for the treatment of major depressive disorder. The efficacy of PAXIL CR in the treatment of a major depressive episode was established in two 12-week controlled trials of outpatients whose diagnoses corresponded to the DSM-IV category of major depressive disorder (see CLINICAL PHARMACOLOGY—Clinical Trials). A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed mood or loss of interest or pleasure in nearly all activities, representing a change from previous functioning, and includes the presence of at least 5 of the following 9 symptoms during the same 2-week period: Depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt, or suicidal ideation. The antidepressant action of paroxetine in hospitalized depressed patients has not been adequately studied. PAXIL CR has not been systematically evaluat…

Source: FDA labeling via NIH DailyMed (set 4f4a52b2…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.